ロード中...
Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanercept
BACKGROUND: Data from routine clinical practice are needed to further define the efficacy and safety of biologic medications in children with juvenile idiopathic arthritis (JIA). The aim of this analysis was to investigate the disease status, reasons for discontinuation and adverse events in Italian...
保存先:
| 出版年: | Pediatr Rheumatol Online J |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2016
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5170898/ https://ncbi.nlm.nih.gov/pubmed/27993144 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12969-016-0126-0 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|